Black Rock Inc. Verrica Pharmaceuticals Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,129,143 shares of VRCA stock, worth $8.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,129,143

Previous 1,114,060 1.35%

Holding current value

$8.98 Million

Previous $6.6 Million 24.81%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.56 $88,838 - $144,193	15,083 Added 1.35%	1,129,143 $8.23 Million
Q1 2024 May 10, 2024	SELL	$4.74 - $6.81 $102,777 - $147,661	-21,683 Reduced 1.91%	1,114,060 $6.6 Million
Q4 2023 Feb 13, 2024	BUY	$2.93 - $7.32 $248,150 - $619,952	84,693 Added 8.06%	1,135,743 $8.31 Million
Q3 2023 Nov 13, 2023	BUY	$3.75 - $7.46 $178,762 - $355,618	47,670 Added 4.75%	1,051,050 $4.08 Million
Q2 2023 Aug 11, 2023	BUY	$5.32 - $6.79 $4.77 Million - $6.09 Million	896,712 Added 840.66%	1,003,380 $5.79 Million

Q1 2023 May 12, 2023	BUY	$2.88 - $8.51 $62,809 - $185,594	21,809 Added 25.7%	106,668 $693,000
Q4 2022 Feb 13, 2023	SELL	$2.09 - $3.39 $406,373 - $659,141	-194,437 Reduced 69.62%	84,859 $233,000
Q3 2022 Nov 14, 2022	BUY	$2.17 - $4.3 $146,750 - $290,796	67,627 Added 31.95%	279,296 $816,000
Q2 2022 Aug 12, 2022	SELL	$1.81 - $8.93 $1.03 Million - $5.07 Million	-568,151 Reduced 72.86%	211,669 $407,000
Q1 2022 May 12, 2022	SELL	$7.59 - $9.49 $111,163 - $138,990	-14,646 Reduced 1.84%	779,820 $6.32 Million
Q4 2021 Feb 10, 2022	BUY	$9.1 - $13.36 $1.36 Million - $1.99 Million	149,248 Added 23.13%	794,466 $7.28 Million
Q3 2021 Nov 09, 2021	SELL	$9.55 - $13.96 $550,318 - $804,445	-57,625 Reduced 8.2%	645,218 $8.07 Million
Q2 2021 Aug 11, 2021	BUY	$9.77 - $15.33 $6.87 Million - $10.8 Million	702,843 New	702,843 $7.94 Million

Others Institutions Holding VRCA

# of Institutions

Shares Held

1.14M

Call Options Held

Put Options Held

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account